MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $450,523 | -30.1% | 94,055 | -0.0% | 0.00% | – |
| Q2 2023 | $644,516 | -6.5% | 94,090 | +6.4% | 0.00% | – |
| Q1 2023 | $689,064 | +1.4% | 88,455 | -0.9% | 0.00% | – |
| Q4 2022 | $679,512 | -5.1% | 89,292 | +1.9% | 0.00% | – |
| Q3 2022 | $716,000 | +5.4% | 87,632 | +24.8% | 0.00% | – |
| Q2 2022 | $679,000 | -34.8% | 70,208 | -5.5% | 0.00% | – |
| Q1 2022 | $1,042,000 | +59.6% | 74,319 | +132.4% | 0.00% | – |
| Q4 2021 | $653,000 | +5.2% | 31,979 | +14.8% | 0.00% | – |
| Q3 2021 | $621,000 | – | 27,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |